CarbetocinHormone TherapySafety Rating 8/10

Primary research areaPrevention of postpartum hemorrhage (not US approved)

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range100 mcg IV or IM single dose
AdministrationIV or IM injection
Safety8/10 · WHO Essential Medicine
NCAA D1Not listed

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Carbetocin

Mechanism of action

Long-acting oxytocin analog; sustained uterotonic effect after delivery

Safety profile

Nausea, flushing, hypotension, headache · WHO Essential Medicine for postpartum hemorrhage; well-tolerated; approved in many countries

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Carbetocin

Failed to fetch